203 related articles for article (PubMed ID: 16006472)
1. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
3. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
4. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
5. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
[TBL] [Abstract][Full Text] [Related]
6. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
7. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
[TBL] [Abstract][Full Text] [Related]
8. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
9. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies.
Maymon R; Dreazen E; Rozinsky S; Bukovsky I; Weinraub Z; Herman A
Prenat Diagn; 1999 Nov; 19(11):1007-11. PubMed ID: 10589049
[TBL] [Abstract][Full Text] [Related]
12. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies.
Maymon R; Shulman A
Prenat Diagn; 2004 Feb; 24(2):125-9. PubMed ID: 14974121
[TBL] [Abstract][Full Text] [Related]
13. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
14. Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21.
Spencer K; de Kok JB; Swinkels DW
Prenat Diagn; 2003 Jul; 23(7):580-3. PubMed ID: 12868088
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection.
Hui PW; Lam YH; Tang MH; NG EH; Yeung WS; Ho PC
Prenat Diagn; 2005 May; 25(5):390-3. PubMed ID: 15906430
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
[TBL] [Abstract][Full Text] [Related]
18. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
19. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
Bellver J; Lara C; Soares SR; Ramírez A; Pellicer A; Remohí J; Serra V
Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
[TBL] [Abstract][Full Text] [Related]
20. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
